Sir Patrick Vallance, the UK’s chief scientific adviser, has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest
— The Telegraph (@Telegraph) September 24, 2020